Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amarin Corp ADR (NQ: AMRN ) 0.5801 +0.0101 (+1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amarin Corp ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday November 08, 2022 Gainers Via Benzinga Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care November 07, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin (AMRN) Q3 2022 Earnings Call Transcript October 27, 2022 AMRN earnings call for the period ending September 30, 2022. Via The Motley Fool Amarin Corp: Q3 Earnings Insights October 27, 2022 Amarin Corp (NASDAQ:AMRN) reported its Q3 earnings results on Thursday, October 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session November 07, 2022 Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. Via Benzinga Amarin Corp Earnings Perspective: Return On Capital Employed October 31, 2022 According to data from Benzinga Pro, during Q3, Amarin Corp's (NASDAQ:AMRN) reported sales totaled $89.88 million. Despite a 92.65% increase in earnings, the company posted a loss of $5.14 million. Via Benzinga Amarin Reports Third Quarter 2022 Financial Results and Provides Business Update October 27, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers August 29, 2022 Via Benzinga Amarin Corp Earnings Perspective: Return On Capital Employed August 08, 2022 Via Benzinga Amarin Still Suspends FY22 Guidance On Generic Challenges August 03, 2022 Via Benzinga Earnings Preview For Amarin Corp October 26, 2022 Amarin Corp (NASDAQ:AMRN) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that Amarin Corp... Via Benzinga Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors October 20, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin to Report Third Quarter 2022 Financial Results And Host Conference Call on October 27, 2022 October 20, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin Board of Directors Issues Statement in Response to Sarissa October 11, 2022 From Amarin Corporation plc Via GlobeNewswire Amarin Corp: Q2 Earnings Insights August 03, 2022 Amarin Corp (NASDAQ:AMRN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Sarissa Capital Has Commenced the Process to Call a Special Meeting of Amarin Shareholders to Remove and Replace Certain Board Members October 11, 2022 From Sarissa Capital Management LP Via Business Wire 3 Biotech Stocks Gaining Momentum September 12, 2022 The headlines have been particularly good for a trio of small cap biotechs and it appears the momentum may have staying power. Via MarketBeat MarketBeat: Week in Review 8/22 - 8/26 August 27, 2022 The markets are selling on news that interest rate hikes will continue past September. But here are some of the other stories for investors to follow this week Via MarketBeat Topics Economy Exposures Interest Rates Amarin's New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes August 26, 2022 New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes... Via Benzinga 7 F-Rated Growth Stocks to Sell Before Q4 August 25, 2022 Challenging market conditions make these growth stocks to sell a detriment to your portfolio if you don't dump them before Q4. Via InvestorPlace Are Ocugen or Amarin Good Penny Stocks to Buy? August 24, 2022 This article discusses the current state of Ocugen and Amarin, two penny stocks that highlight the risk and (potential) reward of penny stock investing. Via MarketBeat Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday August 23, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 22, 2022 Via Benzinga Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session August 22, 2022 Losers Via Benzinga AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday August 22, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session August 19, 2022 Gainers Via Benzinga Does Amarin Deserve a Spot in Your Portfolio after Earnings ? August 04, 2022 Amarin recently announced its earnings for Q2'22 with mixed results. Here we'll examine the pros and cons of having this penny stock in your portfolio. Via MarketBeat Topics Earnings Exposures Financial Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial August 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket August 03, 2022 Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. Via Benzinga Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session July 01, 2022 Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday. Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.